Literature DB >> 23372292

Morbidly adherent placenta: a critical review.

Richa Aggarwal1, Amita Suneja, Neelam Bala Vaid, Ponam Yadav, Abha Sharma, Kiran Mishra.   

Abstract

OBJECTIVE: To evaluate the demographic profile, high risk factors, fetomaternal outcome and management options in morbidly adherent placenta (MAP). STUDY
DESIGN: Retrospective analysis.
METHODOLOGY: Review of 20 case records of women with MAP during year 2001-2006.
RESULTS: The mean age and parity of the women was 27.7 ± 4.2 years and 2.5 respectively. 70 % women had previous uterine scar, and similar number had placenta previa. 60 % women presented with antepartum hemorrhage and 20 % with retained placenta. 85 % women underwent hysterectomy with 5 % requiring internal iliac artery ligation, another 5 % partial cystectomy and 15 % bladder repair. Blood loss was between one and nine litres requiring an average of six units whole blood and 4 units FFP. There were six (30 %) maternal deaths. 55 % of the newborns were preterm and the perinatal mortality was 33.3 %.
CONCLUSION: Cesarean section and placenta previa are significant risk factors. MAP is associated with high fetomaternal morbidity and mortality.

Entities:  

Keywords:  Internal iliac artery ligation; Morbidly adherent placenta; Placenta accreta; Placenta increta; Placenta percreta

Year:  2012        PMID: 23372292      PMCID: PMC3366567          DOI: 10.1007/s13224-012-0149-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  15 in total

1.  'Conservative' management of placenta praevia percreta: report of two cases and discussion of current management options.

Authors:  Michael J Bennett; Rahul C Sen
Journal:  Aust N Z J Obstet Gynaecol       Date:  2003-06       Impact factor: 2.100

2.  Maternal complications associated with multiple cesarean deliveries.

Authors:  Victoria Nisenblat; Shlomi Barak; Ofra Barnett Griness; Simon Degani; Gonen Ohel; Ron Gonen
Journal:  Obstet Gynecol       Date:  2006-07       Impact factor: 7.661

3.  Placenta accreta and methotrexate therapy: three case reports.

Authors:  G M Mussalli; J Shah; D J Berck; A Elimian; N Tejani; F A Manning
Journal:  J Perinatol       Date:  2000 Jul-Aug       Impact factor: 2.521

4.  The management of placenta percreta: conservative and operative strategies.

Authors:  J M O'Brien; J R Barton; E S Donaldson
Journal:  Am J Obstet Gynecol       Date:  1996-12       Impact factor: 8.661

5.  Placenta accreta diagnosed at 9 weeks' gestation.

Authors:  Y-J Chen; P-H Wang; W-M Liu; C-R Lai; L-P Shu; J-H Hung
Journal:  Ultrasound Obstet Gynecol       Date:  2002-06       Impact factor: 7.299

6.  Placenta accreta--summary of 10 years: a survey of 310 cases.

Authors:  Y Gielchinsky; N Rojansky; S J Fasouliotis; Y Ezra
Journal:  Placenta       Date:  2002 Feb-Mar       Impact factor: 3.481

7.  ACOG Committee opinion. Number 266, January 2002 : placenta accreta.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-01       Impact factor: 7.661

8.  Conservative versus extirpative management in cases of placenta accreta.

Authors:  Gilles Kayem; Céline Davy; François Goffinet; Carole Thomas; Denis Clément; Dominique Cabrol
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

9.  Emergency peripartum hysterectomy: experience at a community teaching hospital.

Authors:  Elana S Kastner; Reinaldo Figueroa; David Garry; Dev Maulik
Journal:  Obstet Gynecol       Date:  2002-06       Impact factor: 7.661

10.  The early sonographic appearance of placenta accreta.

Authors:  Christine H Comstock; Wesley Lee; Ivana M Vettraino; Richard A Bronsteen
Journal:  J Ultrasound Med       Date:  2003-01       Impact factor: 2.153

View more
  7 in total

Review 1.  Urological Manifestations of Placenta Percreta.

Authors:  Mina A Ibrahim; Angela Liu; Amanda Dalpiaz; Richard Schwamb; Kelly Warren; Sardar A Khan
Journal:  Curr Urol       Date:  2015-07-10

2.  Morbidly Adherent Placenta: Its Management and Maternal and Perinatal Outcome.

Authors:  H K Chaudhari; P K Shah; Natasha D'Souza
Journal:  J Obstet Gynaecol India       Date:  2016-07-07

3.  A retrospective analysis of maternal complications and newborn outcomes of general anesthesia for cesarean delivery in a single tertiary hospital in China.

Authors:  Yang Bao; Ting Zhang; Ling Li; Changqing Zhou; Minxian Liang; Jie Zhou; Chunling Wang
Journal:  BMC Anesthesiol       Date:  2022-07-06       Impact factor: 2.376

4.  Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions.

Authors:  Vindya Wijesinghe; Mohamed Rishard; Sriskanthan Srisanjeevan
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-23       Impact factor: 3.105

5.  A comparison of cell-free placental messenger ribonucleic acid and color Doppler ultrasound for the prediction of placental invasion in patients with placenta accreta.

Authors:  Elham Naghshineh; Elahe Khorvash; Sara Kamali
Journal:  Adv Biomed Res       Date:  2015-01-30

6.  Use of Bladder Filling to Prevent Urinary System Complications in the Management of Placenta Percreta: a Randomized Prospective Study.

Authors:  Hüseyin Çağlayan Özcan; Özcan Balat; Mete Gurol Uğur; Seyhun Sucu; Neslihan Bayramoğlu Tepe; Tanyeli Güneyligil Kazaz
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-02-19       Impact factor: 2.915

7.  Effect of site of placentation on pregnancy outcomes in patients with placenta previa.

Authors:  Lin Jing; Gu Wei; Song Mengfan; Hou Yanyan
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.